nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—coronary artery disease	0.445	1	CbGaD
Octreotide—Felypressin—AVPR1A—coronary artery disease	0.00294	0.462	CrCbGaD
Octreotide—Terlipressin—AVPR1A—coronary artery disease	0.00182	0.286	CrCbGaD
Octreotide—Desmopressin—AVPR1A—coronary artery disease	0.00143	0.224	CrCbGaD
Octreotide—Desmopressin—PTGS2—coronary artery disease	0.000178	0.028	CrCbGaD
Octreotide—Rash—Ezetimibe—coronary artery disease	5.97e-05	0.000194	CcSEcCtD
Octreotide—Dermatitis—Ezetimibe—coronary artery disease	5.96e-05	0.000194	CcSEcCtD
Octreotide—Discomfort—Timolol—coronary artery disease	5.96e-05	0.000194	CcSEcCtD
Octreotide—Asthenia—Niacin—coronary artery disease	5.95e-05	0.000194	CcSEcCtD
Octreotide—Fatigue—Losartan—coronary artery disease	5.95e-05	0.000194	CcSEcCtD
Octreotide—Headache—Ezetimibe—coronary artery disease	5.93e-05	0.000193	CcSEcCtD
Octreotide—Malaise—Lisinopril—coronary artery disease	5.93e-05	0.000193	CcSEcCtD
Octreotide—Anaphylactic shock—Ramipril—coronary artery disease	5.91e-05	0.000193	CcSEcCtD
Octreotide—Oedema—Ramipril—coronary artery disease	5.91e-05	0.000193	CcSEcCtD
Octreotide—Vertigo—Lisinopril—coronary artery disease	5.9e-05	0.000192	CcSEcCtD
Octreotide—Dry mouth—Timolol—coronary artery disease	5.9e-05	0.000192	CcSEcCtD
Octreotide—Constipation—Losartan—coronary artery disease	5.9e-05	0.000192	CcSEcCtD
Octreotide—Pain—Losartan—coronary artery disease	5.9e-05	0.000192	CcSEcCtD
Octreotide—Syncope—Lisinopril—coronary artery disease	5.89e-05	0.000192	CcSEcCtD
Octreotide—Vomiting—Eplerenone—coronary artery disease	5.89e-05	0.000192	CcSEcCtD
Octreotide—Feeling abnormal—Furosemide—coronary artery disease	5.89e-05	0.000192	CcSEcCtD
Octreotide—Nausea—Fenofibrate—coronary artery disease	5.87e-05	0.000191	CcSEcCtD
Octreotide—Pruritus—Niacin—coronary artery disease	5.87e-05	0.000191	CcSEcCtD
Octreotide—Asthenia—Pravastatin—coronary artery disease	5.86e-05	0.000191	CcSEcCtD
Octreotide—Gastrointestinal pain—Furosemide—coronary artery disease	5.84e-05	0.00019	CcSEcCtD
Octreotide—Rash—Eplerenone—coronary artery disease	5.84e-05	0.00019	CcSEcCtD
Octreotide—Urticaria—Perindopril—coronary artery disease	5.84e-05	0.00019	CcSEcCtD
Octreotide—Hypersensitivity—Trandolapril—coronary artery disease	5.84e-05	0.00019	CcSEcCtD
Octreotide—Dermatitis—Eplerenone—coronary artery disease	5.84e-05	0.00019	CcSEcCtD
Octreotide—Diarrhoea—Valsartan—coronary artery disease	5.83e-05	0.00019	CcSEcCtD
Octreotide—Shock—Ramipril—coronary artery disease	5.82e-05	0.00019	CcSEcCtD
Octreotide—Hypersensitivity—Enalapril—coronary artery disease	5.82e-05	0.00019	CcSEcCtD
Octreotide—Body temperature increased—Perindopril—coronary artery disease	5.81e-05	0.000189	CcSEcCtD
Octreotide—Abdominal pain—Perindopril—coronary artery disease	5.81e-05	0.000189	CcSEcCtD
Octreotide—Palpitations—Lisinopril—coronary artery disease	5.81e-05	0.000189	CcSEcCtD
Octreotide—Diarrhoea—Olmesartan—coronary artery disease	5.81e-05	0.000189	CcSEcCtD
Octreotide—Headache—Eplerenone—coronary artery disease	5.81e-05	0.000189	CcSEcCtD
Octreotide—Nervous system disorder—Ramipril—coronary artery disease	5.8e-05	0.000189	CcSEcCtD
Octreotide—Thrombocytopenia—Ramipril—coronary artery disease	5.79e-05	0.000189	CcSEcCtD
Octreotide—Anaphylactic shock—Timolol—coronary artery disease	5.78e-05	0.000188	CcSEcCtD
Octreotide—Oedema—Timolol—coronary artery disease	5.78e-05	0.000188	CcSEcCtD
Octreotide—Pruritus—Pravastatin—coronary artery disease	5.78e-05	0.000188	CcSEcCtD
Octreotide—Loss of consciousness—Lisinopril—coronary artery disease	5.77e-05	0.000188	CcSEcCtD
Octreotide—Nausea—Clopidogrel—coronary artery disease	5.77e-05	0.000188	CcSEcCtD
Octreotide—Tachycardia—Ramipril—coronary artery disease	5.77e-05	0.000188	CcSEcCtD
Octreotide—Skin disorder—Ramipril—coronary artery disease	5.74e-05	0.000187	CcSEcCtD
Octreotide—Infection—Timolol—coronary artery disease	5.74e-05	0.000187	CcSEcCtD
Octreotide—Vomiting—Simvastatin—coronary artery disease	5.74e-05	0.000187	CcSEcCtD
Octreotide—Hypersensitivity—Telmisartan—coronary artery disease	5.74e-05	0.000187	CcSEcCtD
Octreotide—Cough—Lisinopril—coronary artery disease	5.73e-05	0.000187	CcSEcCtD
Octreotide—Nausea—Lovastatin—coronary artery disease	5.73e-05	0.000187	CcSEcCtD
Octreotide—Hyperhidrosis—Ramipril—coronary artery disease	5.72e-05	0.000186	CcSEcCtD
Octreotide—Rash—Simvastatin—coronary artery disease	5.69e-05	0.000185	CcSEcCtD
Octreotide—Dermatitis—Simvastatin—coronary artery disease	5.69e-05	0.000185	CcSEcCtD
Octreotide—Asthenia—Trandolapril—coronary artery disease	5.69e-05	0.000185	CcSEcCtD
Octreotide—Shock—Timolol—coronary artery disease	5.69e-05	0.000185	CcSEcCtD
Octreotide—Feeling abnormal—Losartan—coronary artery disease	5.68e-05	0.000185	CcSEcCtD
Octreotide—Urticaria—Furosemide—coronary artery disease	5.68e-05	0.000185	CcSEcCtD
Octreotide—Diarrhoea—Niacin—coronary artery disease	5.67e-05	0.000185	CcSEcCtD
Octreotide—Nervous system disorder—Timolol—coronary artery disease	5.67e-05	0.000185	CcSEcCtD
Octreotide—Asthenia—Enalapril—coronary artery disease	5.66e-05	0.000185	CcSEcCtD
Octreotide—Headache—Simvastatin—coronary artery disease	5.66e-05	0.000184	CcSEcCtD
Octreotide—Abdominal pain—Furosemide—coronary artery disease	5.65e-05	0.000184	CcSEcCtD
Octreotide—Body temperature increased—Furosemide—coronary artery disease	5.65e-05	0.000184	CcSEcCtD
Octreotide—Gastrointestinal pain—Losartan—coronary artery disease	5.64e-05	0.000184	CcSEcCtD
Octreotide—Dizziness—Valsartan—coronary artery disease	5.64e-05	0.000184	CcSEcCtD
Octreotide—Anorexia—Ramipril—coronary artery disease	5.64e-05	0.000184	CcSEcCtD
Octreotide—Nausea—Ezetimibe—coronary artery disease	5.62e-05	0.000183	CcSEcCtD
Octreotide—Skin disorder—Timolol—coronary artery disease	5.61e-05	0.000183	CcSEcCtD
Octreotide—Dizziness—Olmesartan—coronary artery disease	5.61e-05	0.000183	CcSEcCtD
Octreotide—Pruritus—Trandolapril—coronary artery disease	5.61e-05	0.000183	CcSEcCtD
Octreotide—Chest pain—Lisinopril—coronary artery disease	5.59e-05	0.000182	CcSEcCtD
Octreotide—Arthralgia—Lisinopril—coronary artery disease	5.59e-05	0.000182	CcSEcCtD
Octreotide—Myalgia—Lisinopril—coronary artery disease	5.59e-05	0.000182	CcSEcCtD
Octreotide—Hyperhidrosis—Timolol—coronary artery disease	5.59e-05	0.000182	CcSEcCtD
Octreotide—Asthenia—Telmisartan—coronary artery disease	5.59e-05	0.000182	CcSEcCtD
Octreotide—Pruritus—Enalapril—coronary artery disease	5.59e-05	0.000182	CcSEcCtD
Octreotide—Diarrhoea—Pravastatin—coronary artery disease	5.58e-05	0.000182	CcSEcCtD
Octreotide—Anxiety—Lisinopril—coronary artery disease	5.57e-05	0.000182	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.56e-05	0.000181	CcSEcCtD
Octreotide—Discomfort—Lisinopril—coronary artery disease	5.53e-05	0.00018	CcSEcCtD
Octreotide—Anorexia—Timolol—coronary artery disease	5.51e-05	0.00018	CcSEcCtD
Octreotide—Pruritus—Telmisartan—coronary artery disease	5.51e-05	0.000179	CcSEcCtD
Octreotide—Nausea—Eplerenone—coronary artery disease	5.5e-05	0.000179	CcSEcCtD
Octreotide—Dizziness—Niacin—coronary artery disease	5.48e-05	0.000179	CcSEcCtD
Octreotide—Urticaria—Losartan—coronary artery disease	5.48e-05	0.000178	CcSEcCtD
Octreotide—Dry mouth—Lisinopril—coronary artery disease	5.47e-05	0.000178	CcSEcCtD
Octreotide—Body temperature increased—Losartan—coronary artery disease	5.45e-05	0.000178	CcSEcCtD
Octreotide—Abdominal pain—Losartan—coronary artery disease	5.45e-05	0.000178	CcSEcCtD
Octreotide—Asthenia—Captopril—coronary artery disease	5.43e-05	0.000177	CcSEcCtD
Octreotide—Diarrhoea—Trandolapril—coronary artery disease	5.42e-05	0.000177	CcSEcCtD
Octreotide—Vomiting—Valsartan—coronary artery disease	5.42e-05	0.000177	CcSEcCtD
Octreotide—Diarrhoea—Enalapril—coronary artery disease	5.4e-05	0.000176	CcSEcCtD
Octreotide—Dizziness—Pravastatin—coronary artery disease	5.4e-05	0.000176	CcSEcCtD
Octreotide—Vomiting—Olmesartan—coronary artery disease	5.4e-05	0.000176	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.39e-05	0.000176	CcSEcCtD
Octreotide—Rash—Valsartan—coronary artery disease	5.38e-05	0.000175	CcSEcCtD
Octreotide—Dermatitis—Valsartan—coronary artery disease	5.37e-05	0.000175	CcSEcCtD
Octreotide—Nausea—Simvastatin—coronary artery disease	5.36e-05	0.000175	CcSEcCtD
Octreotide—Anaphylactic shock—Lisinopril—coronary artery disease	5.36e-05	0.000175	CcSEcCtD
Octreotide—Oedema—Lisinopril—coronary artery disease	5.36e-05	0.000175	CcSEcCtD
Octreotide—Pruritus—Captopril—coronary artery disease	5.36e-05	0.000175	CcSEcCtD
Octreotide—Rash—Olmesartan—coronary artery disease	5.35e-05	0.000174	CcSEcCtD
Octreotide—Insomnia—Ramipril—coronary artery disease	5.35e-05	0.000174	CcSEcCtD
Octreotide—Dermatitis—Olmesartan—coronary artery disease	5.35e-05	0.000174	CcSEcCtD
Octreotide—Headache—Valsartan—coronary artery disease	5.34e-05	0.000174	CcSEcCtD
Octreotide—Diarrhoea—Telmisartan—coronary artery disease	5.33e-05	0.000174	CcSEcCtD
Octreotide—Infection—Lisinopril—coronary artery disease	5.33e-05	0.000174	CcSEcCtD
Octreotide—Headache—Olmesartan—coronary artery disease	5.32e-05	0.000173	CcSEcCtD
Octreotide—Paraesthesia—Ramipril—coronary artery disease	5.31e-05	0.000173	CcSEcCtD
Octreotide—Shock—Lisinopril—coronary artery disease	5.28e-05	0.000172	CcSEcCtD
Octreotide—Asthenia—Perindopril—coronary artery disease	5.27e-05	0.000172	CcSEcCtD
Octreotide—Dyspnoea—Ramipril—coronary artery disease	5.27e-05	0.000172	CcSEcCtD
Octreotide—Vomiting—Niacin—coronary artery disease	5.27e-05	0.000172	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Timolol—coronary artery disease	5.27e-05	0.000172	CcSEcCtD
Octreotide—Hypersensitivity—Furosemide—coronary artery disease	5.27e-05	0.000172	CcSEcCtD
Octreotide—Somnolence—Ramipril—coronary artery disease	5.26e-05	0.000171	CcSEcCtD
Octreotide—Thrombocytopenia—Lisinopril—coronary artery disease	5.25e-05	0.000171	CcSEcCtD
Octreotide—Dizziness—Trandolapril—coronary artery disease	5.24e-05	0.000171	CcSEcCtD
Octreotide—Tachycardia—Lisinopril—coronary artery disease	5.23e-05	0.000171	CcSEcCtD
Octreotide—Insomnia—Timolol—coronary artery disease	5.23e-05	0.00017	CcSEcCtD
Octreotide—Rash—Niacin—coronary artery disease	5.23e-05	0.00017	CcSEcCtD
Octreotide—Dermatitis—Niacin—coronary artery disease	5.22e-05	0.00017	CcSEcCtD
Octreotide—Dizziness—Enalapril—coronary artery disease	5.22e-05	0.00017	CcSEcCtD
Octreotide—Skin disorder—Lisinopril—coronary artery disease	5.21e-05	0.00017	CcSEcCtD
Octreotide—Dyspepsia—Ramipril—coronary artery disease	5.2e-05	0.00017	CcSEcCtD
Octreotide—Pruritus—Perindopril—coronary artery disease	5.2e-05	0.000169	CcSEcCtD
Octreotide—Headache—Niacin—coronary artery disease	5.19e-05	0.000169	CcSEcCtD
Octreotide—Paraesthesia—Timolol—coronary artery disease	5.19e-05	0.000169	CcSEcCtD
Octreotide—Vomiting—Pravastatin—coronary artery disease	5.19e-05	0.000169	CcSEcCtD
Octreotide—Hyperhidrosis—Lisinopril—coronary artery disease	5.18e-05	0.000169	CcSEcCtD
Octreotide—Diarrhoea—Captopril—coronary artery disease	5.18e-05	0.000169	CcSEcCtD
Octreotide—Dyspnoea—Timolol—coronary artery disease	5.15e-05	0.000168	CcSEcCtD
Octreotide—Dizziness—Telmisartan—coronary artery disease	5.15e-05	0.000168	CcSEcCtD
Octreotide—Rash—Pravastatin—coronary artery disease	5.15e-05	0.000168	CcSEcCtD
Octreotide—Dermatitis—Pravastatin—coronary artery disease	5.14e-05	0.000168	CcSEcCtD
Octreotide—Decreased appetite—Ramipril—coronary artery disease	5.14e-05	0.000167	CcSEcCtD
Octreotide—Somnolence—Timolol—coronary artery disease	5.14e-05	0.000167	CcSEcCtD
Octreotide—Asthenia—Furosemide—coronary artery disease	5.13e-05	0.000167	CcSEcCtD
Octreotide—Headache—Pravastatin—coronary artery disease	5.11e-05	0.000167	CcSEcCtD
Octreotide—Anorexia—Lisinopril—coronary artery disease	5.11e-05	0.000167	CcSEcCtD
Octreotide—Gastrointestinal disorder—Ramipril—coronary artery disease	5.1e-05	0.000166	CcSEcCtD
Octreotide—Fatigue—Ramipril—coronary artery disease	5.1e-05	0.000166	CcSEcCtD
Octreotide—Dyspepsia—Timolol—coronary artery disease	5.09e-05	0.000166	CcSEcCtD
Octreotide—Hypersensitivity—Losartan—coronary artery disease	5.08e-05	0.000166	CcSEcCtD
Octreotide—Nausea—Valsartan—coronary artery disease	5.06e-05	0.000165	CcSEcCtD
Octreotide—Pruritus—Furosemide—coronary artery disease	5.06e-05	0.000165	CcSEcCtD
Octreotide—Constipation—Ramipril—coronary artery disease	5.06e-05	0.000165	CcSEcCtD
Octreotide—Nausea—Olmesartan—coronary artery disease	5.04e-05	0.000164	CcSEcCtD
Octreotide—Vomiting—Trandolapril—coronary artery disease	5.04e-05	0.000164	CcSEcCtD
Octreotide—Diarrhoea—Perindopril—coronary artery disease	5.03e-05	0.000164	CcSEcCtD
Octreotide—Decreased appetite—Timolol—coronary artery disease	5.02e-05	0.000164	CcSEcCtD
Octreotide—Vomiting—Enalapril—coronary artery disease	5.02e-05	0.000164	CcSEcCtD
Octreotide—Dizziness—Captopril—coronary artery disease	5.01e-05	0.000163	CcSEcCtD
Octreotide—Rash—Trandolapril—coronary artery disease	5e-05	0.000163	CcSEcCtD
Octreotide—Dermatitis—Trandolapril—coronary artery disease	4.99e-05	0.000163	CcSEcCtD
Octreotide—Gastrointestinal disorder—Timolol—coronary artery disease	4.99e-05	0.000163	CcSEcCtD
Octreotide—Fatigue—Timolol—coronary artery disease	4.98e-05	0.000162	CcSEcCtD
Octreotide—Rash—Enalapril—coronary artery disease	4.98e-05	0.000162	CcSEcCtD
Octreotide—Dermatitis—Enalapril—coronary artery disease	4.97e-05	0.000162	CcSEcCtD
Octreotide—Headache—Trandolapril—coronary artery disease	4.97e-05	0.000162	CcSEcCtD
Octreotide—Vomiting—Telmisartan—coronary artery disease	4.95e-05	0.000161	CcSEcCtD
Octreotide—Asthenia—Losartan—coronary artery disease	4.95e-05	0.000161	CcSEcCtD
Octreotide—Headache—Enalapril—coronary artery disease	4.95e-05	0.000161	CcSEcCtD
Octreotide—Pain—Timolol—coronary artery disease	4.94e-05	0.000161	CcSEcCtD
Octreotide—Nausea—Niacin—coronary artery disease	4.92e-05	0.00016	CcSEcCtD
Octreotide—Rash—Telmisartan—coronary artery disease	4.91e-05	0.00016	CcSEcCtD
Octreotide—Dermatitis—Telmisartan—coronary artery disease	4.91e-05	0.00016	CcSEcCtD
Octreotide—Diarrhoea—Furosemide—coronary artery disease	4.89e-05	0.000159	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.89e-05	0.000159	CcSEcCtD
Octreotide—Pruritus—Losartan—coronary artery disease	4.88e-05	0.000159	CcSEcCtD
Octreotide—Headache—Telmisartan—coronary artery disease	4.88e-05	0.000159	CcSEcCtD
Octreotide—Feeling abnormal—Ramipril—coronary artery disease	4.87e-05	0.000159	CcSEcCtD
Octreotide—Dizziness—Perindopril—coronary artery disease	4.86e-05	0.000158	CcSEcCtD
Octreotide—Insomnia—Lisinopril—coronary artery disease	4.85e-05	0.000158	CcSEcCtD
Octreotide—Nausea—Pravastatin—coronary artery disease	4.85e-05	0.000158	CcSEcCtD
Octreotide—Gastrointestinal pain—Ramipril—coronary artery disease	4.84e-05	0.000158	CcSEcCtD
Octreotide—Paraesthesia—Lisinopril—coronary artery disease	4.82e-05	0.000157	CcSEcCtD
Octreotide—Vomiting—Captopril—coronary artery disease	4.81e-05	0.000157	CcSEcCtD
Octreotide—Dyspnoea—Lisinopril—coronary artery disease	4.78e-05	0.000156	CcSEcCtD
Octreotide—Rash—Captopril—coronary artery disease	4.77e-05	0.000156	CcSEcCtD
Octreotide—Dermatitis—Captopril—coronary artery disease	4.77e-05	0.000155	CcSEcCtD
Octreotide—Somnolence—Lisinopril—coronary artery disease	4.77e-05	0.000155	CcSEcCtD
Octreotide—Feeling abnormal—Timolol—coronary artery disease	4.76e-05	0.000155	CcSEcCtD
Octreotide—Headache—Captopril—coronary artery disease	4.74e-05	0.000155	CcSEcCtD
Octreotide—Gastrointestinal pain—Timolol—coronary artery disease	4.73e-05	0.000154	CcSEcCtD
Octreotide—Dizziness—Furosemide—coronary artery disease	4.73e-05	0.000154	CcSEcCtD
Octreotide—Dyspepsia—Lisinopril—coronary artery disease	4.72e-05	0.000154	CcSEcCtD
Octreotide—Diarrhoea—Losartan—coronary artery disease	4.72e-05	0.000154	CcSEcCtD
Octreotide—Nausea—Trandolapril—coronary artery disease	4.71e-05	0.000153	CcSEcCtD
Octreotide—Urticaria—Ramipril—coronary artery disease	4.7e-05	0.000153	CcSEcCtD
Octreotide—Nausea—Enalapril—coronary artery disease	4.69e-05	0.000153	CcSEcCtD
Octreotide—Vomiting—Perindopril—coronary artery disease	4.67e-05	0.000152	CcSEcCtD
Octreotide—Abdominal pain—Ramipril—coronary artery disease	4.67e-05	0.000152	CcSEcCtD
Octreotide—Body temperature increased—Ramipril—coronary artery disease	4.67e-05	0.000152	CcSEcCtD
Octreotide—Decreased appetite—Lisinopril—coronary artery disease	4.66e-05	0.000152	CcSEcCtD
Octreotide—Rash—Perindopril—coronary artery disease	4.64e-05	0.000151	CcSEcCtD
Octreotide—Dermatitis—Perindopril—coronary artery disease	4.63e-05	0.000151	CcSEcCtD
Octreotide—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.63e-05	0.000151	CcSEcCtD
Octreotide—Nausea—Telmisartan—coronary artery disease	4.63e-05	0.000151	CcSEcCtD
Octreotide—Fatigue—Lisinopril—coronary artery disease	4.62e-05	0.000151	CcSEcCtD
Octreotide—Headache—Perindopril—coronary artery disease	4.61e-05	0.00015	CcSEcCtD
Octreotide—Urticaria—Timolol—coronary artery disease	4.59e-05	0.00015	CcSEcCtD
Octreotide—Pain—Lisinopril—coronary artery disease	4.59e-05	0.000149	CcSEcCtD
Octreotide—Constipation—Lisinopril—coronary artery disease	4.59e-05	0.000149	CcSEcCtD
Octreotide—Body temperature increased—Timolol—coronary artery disease	4.57e-05	0.000149	CcSEcCtD
Octreotide—Abdominal pain—Timolol—coronary artery disease	4.57e-05	0.000149	CcSEcCtD
Octreotide—Dizziness—Losartan—coronary artery disease	4.56e-05	0.000149	CcSEcCtD
Octreotide—Vomiting—Furosemide—coronary artery disease	4.54e-05	0.000148	CcSEcCtD
Octreotide—Rash—Furosemide—coronary artery disease	4.51e-05	0.000147	CcSEcCtD
Octreotide—Dermatitis—Furosemide—coronary artery disease	4.5e-05	0.000147	CcSEcCtD
Octreotide—Nausea—Captopril—coronary artery disease	4.5e-05	0.000147	CcSEcCtD
Octreotide—Headache—Furosemide—coronary artery disease	4.48e-05	0.000146	CcSEcCtD
Octreotide—Feeling abnormal—Lisinopril—coronary artery disease	4.42e-05	0.000144	CcSEcCtD
Octreotide—Gastrointestinal pain—Lisinopril—coronary artery disease	4.38e-05	0.000143	CcSEcCtD
Octreotide—Vomiting—Losartan—coronary artery disease	4.38e-05	0.000143	CcSEcCtD
Octreotide—Nausea—Perindopril—coronary artery disease	4.37e-05	0.000142	CcSEcCtD
Octreotide—Hypersensitivity—Ramipril—coronary artery disease	4.36e-05	0.000142	CcSEcCtD
Octreotide—Rash—Losartan—coronary artery disease	4.35e-05	0.000142	CcSEcCtD
Octreotide—Dermatitis—Losartan—coronary artery disease	4.34e-05	0.000142	CcSEcCtD
Octreotide—Headache—Losartan—coronary artery disease	4.32e-05	0.000141	CcSEcCtD
Octreotide—Urticaria—Lisinopril—coronary artery disease	4.26e-05	0.000139	CcSEcCtD
Octreotide—Hypersensitivity—Timolol—coronary artery disease	4.26e-05	0.000139	CcSEcCtD
Octreotide—Nausea—Furosemide—coronary artery disease	4.25e-05	0.000138	CcSEcCtD
Octreotide—Asthenia—Ramipril—coronary artery disease	4.24e-05	0.000138	CcSEcCtD
Octreotide—Abdominal pain—Lisinopril—coronary artery disease	4.24e-05	0.000138	CcSEcCtD
Octreotide—Body temperature increased—Lisinopril—coronary artery disease	4.24e-05	0.000138	CcSEcCtD
Octreotide—Pruritus—Ramipril—coronary artery disease	4.18e-05	0.000136	CcSEcCtD
Octreotide—Asthenia—Timolol—coronary artery disease	4.15e-05	0.000135	CcSEcCtD
Octreotide—Nausea—Losartan—coronary artery disease	4.1e-05	0.000133	CcSEcCtD
Octreotide—Pruritus—Timolol—coronary artery disease	4.09e-05	0.000133	CcSEcCtD
Octreotide—Diarrhoea—Ramipril—coronary artery disease	4.05e-05	0.000132	CcSEcCtD
Octreotide—Diarrhoea—Timolol—coronary artery disease	3.96e-05	0.000129	CcSEcCtD
Octreotide—Hypersensitivity—Lisinopril—coronary artery disease	3.95e-05	0.000129	CcSEcCtD
Octreotide—Dizziness—Ramipril—coronary artery disease	3.91e-05	0.000127	CcSEcCtD
Octreotide—Asthenia—Lisinopril—coronary artery disease	3.85e-05	0.000125	CcSEcCtD
Octreotide—Dizziness—Timolol—coronary artery disease	3.82e-05	0.000125	CcSEcCtD
Octreotide—Pruritus—Lisinopril—coronary artery disease	3.79e-05	0.000124	CcSEcCtD
Octreotide—Vomiting—Ramipril—coronary artery disease	3.76e-05	0.000122	CcSEcCtD
Octreotide—Rash—Ramipril—coronary artery disease	3.73e-05	0.000121	CcSEcCtD
Octreotide—Dermatitis—Ramipril—coronary artery disease	3.72e-05	0.000121	CcSEcCtD
Octreotide—Headache—Ramipril—coronary artery disease	3.7e-05	0.000121	CcSEcCtD
Octreotide—Vomiting—Timolol—coronary artery disease	3.68e-05	0.00012	CcSEcCtD
Octreotide—Diarrhoea—Lisinopril—coronary artery disease	3.67e-05	0.00012	CcSEcCtD
Octreotide—Rash—Timolol—coronary artery disease	3.64e-05	0.000119	CcSEcCtD
Octreotide—Dermatitis—Timolol—coronary artery disease	3.64e-05	0.000119	CcSEcCtD
Octreotide—Headache—Timolol—coronary artery disease	3.62e-05	0.000118	CcSEcCtD
Octreotide—Dizziness—Lisinopril—coronary artery disease	3.55e-05	0.000116	CcSEcCtD
Octreotide—Nausea—Ramipril—coronary artery disease	3.51e-05	0.000114	CcSEcCtD
Octreotide—Nausea—Timolol—coronary artery disease	3.43e-05	0.000112	CcSEcCtD
Octreotide—Vomiting—Lisinopril—coronary artery disease	3.41e-05	0.000111	CcSEcCtD
Octreotide—Rash—Lisinopril—coronary artery disease	3.38e-05	0.00011	CcSEcCtD
Octreotide—Dermatitis—Lisinopril—coronary artery disease	3.38e-05	0.00011	CcSEcCtD
Octreotide—Headache—Lisinopril—coronary artery disease	3.36e-05	0.000109	CcSEcCtD
Octreotide—Nausea—Lisinopril—coronary artery disease	3.19e-05	0.000104	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—LPL—coronary artery disease	1.83e-05	7.6e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GSK3B—coronary artery disease	1.83e-05	7.59e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—POMC—coronary artery disease	1.83e-05	7.58e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CREB1—coronary artery disease	1.83e-05	7.58e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR1—coronary artery disease	1.83e-05	7.56e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOCS3—coronary artery disease	1.83e-05	7.56e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—POMC—coronary artery disease	1.82e-05	7.53e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CREB1—coronary artery disease	1.82e-05	7.53e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MEF2C—coronary artery disease	1.82e-05	7.53e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RPS6KB1—coronary artery disease	1.82e-05	7.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—coronary artery disease	1.8e-05	7.47e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KITLG—coronary artery disease	1.8e-05	7.47e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFBR2—coronary artery disease	1.8e-05	7.47e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PPP2CA—coronary artery disease	1.79e-05	7.44e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL2—coronary artery disease	1.79e-05	7.42e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6R—coronary artery disease	1.79e-05	7.4e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL10—coronary artery disease	1.78e-05	7.39e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL2—coronary artery disease	1.78e-05	7.37e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLG—coronary artery disease	1.78e-05	7.37e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6R—coronary artery disease	1.77e-05	7.35e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ITGB3—coronary artery disease	1.77e-05	7.34e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP3—coronary artery disease	1.76e-05	7.3e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT5A—coronary artery disease	1.76e-05	7.3e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCD—coronary artery disease	1.76e-05	7.3e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF1—coronary artery disease	1.75e-05	7.24e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MAPK1—coronary artery disease	1.74e-05	7.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRB2—coronary artery disease	1.73e-05	7.17e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—coronary artery disease	1.73e-05	7.17e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HTR2A—coronary artery disease	1.72e-05	7.15e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—C3—coronary artery disease	1.72e-05	7.14e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PPP2CA—coronary artery disease	1.72e-05	7.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCE—coronary artery disease	1.71e-05	7.08e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—JAK2—coronary artery disease	1.71e-05	7.08e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS1—coronary artery disease	1.71e-05	7.06e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOB—coronary artery disease	1.7e-05	7.06e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—S100B—coronary artery disease	1.7e-05	7.05e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCD—coronary artery disease	1.69e-05	7e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—coronary artery disease	1.69e-05	7e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOCS3—coronary artery disease	1.68e-05	6.98e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—JAK2—coronary artery disease	1.68e-05	6.96e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EDN1—coronary artery disease	1.68e-05	6.95e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KITLG—coronary artery disease	1.66e-05	6.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFBR2—coronary artery disease	1.66e-05	6.9e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL5—coronary artery disease	1.66e-05	6.89e-05	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—coronary artery disease	1.66e-05	6.89e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—coronary artery disease	1.66e-05	6.88e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HTR2A—coronary artery disease	1.65e-05	6.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C3—coronary artery disease	1.65e-05	6.84e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HIF1A—coronary artery disease	1.64e-05	6.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF1—coronary artery disease	1.64e-05	6.79e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CSF2—coronary artery disease	1.64e-05	6.79e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—coronary artery disease	1.64e-05	6.78e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT5A—coronary artery disease	1.63e-05	6.74e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LPL—coronary artery disease	1.63e-05	6.74e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP3—coronary artery disease	1.63e-05	6.74e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MEF2C—coronary artery disease	1.61e-05	6.68e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RPS6KB1—coronary artery disease	1.61e-05	6.68e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGF2—coronary artery disease	1.61e-05	6.66e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—coronary artery disease	1.6e-05	6.64e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LEP—coronary artery disease	1.6e-05	6.64e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOA1—coronary artery disease	1.59e-05	6.57e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOS3—coronary artery disease	1.59e-05	6.57e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HIF1A—coronary artery disease	1.57e-05	6.53e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOB—coronary artery disease	1.57e-05	6.51e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ITGB3—coronary artery disease	1.57e-05	6.51e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—coronary artery disease	1.57e-05	6.51e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—coronary artery disease	1.57e-05	6.5e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK14—coronary artery disease	1.56e-05	6.47e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—coronary artery disease	1.56e-05	6.46e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—JAK2—coronary artery disease	1.55e-05	6.43e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDN1—coronary artery disease	1.55e-05	6.41e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JAK2—coronary artery disease	1.54e-05	6.38e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—coronary artery disease	1.54e-05	6.37e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—coronary artery disease	1.54e-05	6.37e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL5—coronary artery disease	1.54e-05	6.36e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—coronary artery disease	1.53e-05	6.36e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ESR1—coronary artery disease	1.53e-05	6.34e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PPP2CA—coronary artery disease	1.53e-05	6.32e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOA1—coronary artery disease	1.52e-05	6.3e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—F2—coronary artery disease	1.51e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CSF2—coronary artery disease	1.51e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF1—coronary artery disease	1.51e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FN1—coronary artery disease	1.51e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—coronary artery disease	1.51e-05	6.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—coronary artery disease	1.51e-05	6.24e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6ST—coronary artery disease	1.51e-05	6.24e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LPL—coronary artery disease	1.5e-05	6.22e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCD—coronary artery disease	1.5e-05	6.21e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK14—coronary artery disease	1.5e-05	6.2e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NFKBIA—coronary artery disease	1.49e-05	6.19e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RPS6KB1—coronary artery disease	1.49e-05	6.16e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MEF2C—coronary artery disease	1.49e-05	6.16e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ESR1—coronary artery disease	1.47e-05	6.08e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HTR2A—coronary artery disease	1.47e-05	6.08e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—C3—coronary artery disease	1.46e-05	6.07e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ITGB3—coronary artery disease	1.45e-05	6.01e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—F2—coronary artery disease	1.45e-05	6.01e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FN1—coronary artery disease	1.45e-05	6.01e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KIT—coronary artery disease	1.45e-05	6e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6ST—coronary artery disease	1.44e-05	5.98e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NFKBIA—coronary artery disease	1.43e-05	5.94e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—coronary artery disease	1.42e-05	5.87e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PPP2CA—coronary artery disease	1.41e-05	5.84e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—coronary artery disease	1.41e-05	5.83e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—coronary artery disease	1.4e-05	5.79e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—coronary artery disease	1.39e-05	5.77e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GSK3B—coronary artery disease	1.39e-05	5.75e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—coronary artery disease	1.39e-05	5.75e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCD—coronary artery disease	1.38e-05	5.73e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—coronary artery disease	1.38e-05	5.71e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CREB1—coronary artery disease	1.38e-05	5.71e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—coronary artery disease	1.36e-05	5.65e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—coronary artery disease	1.36e-05	5.65e-05	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—coronary artery disease	1.36e-05	5.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR2A—coronary artery disease	1.35e-05	5.61e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C3—coronary artery disease	1.35e-05	5.6e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOA1—coronary artery disease	1.35e-05	5.58e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL2—coronary artery disease	1.35e-05	5.58e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—coronary artery disease	1.35e-05	5.58e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6R—coronary artery disease	1.34e-05	5.57e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—coronary artery disease	1.34e-05	5.54e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—coronary artery disease	1.34e-05	5.53e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GSK3B—coronary artery disease	1.33e-05	5.52e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK14—coronary artery disease	1.33e-05	5.5e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—coronary artery disease	1.33e-05	5.49e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—POMC—coronary artery disease	1.32e-05	5.47e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CREB1—coronary artery disease	1.32e-05	5.47e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK1—coronary artery disease	1.32e-05	5.46e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—coronary artery disease	1.31e-05	5.43e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ESR1—coronary artery disease	1.3e-05	5.39e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL2—coronary artery disease	1.29e-05	5.35e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIF1A—coronary artery disease	1.29e-05	5.34e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6R—coronary artery disease	1.29e-05	5.34e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—F2—coronary artery disease	1.29e-05	5.33e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FN1—coronary artery disease	1.29e-05	5.33e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—coronary artery disease	1.28e-05	5.32e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6ST—coronary artery disease	1.28e-05	5.31e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—coronary artery disease	1.27e-05	5.27e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NFKBIA—coronary artery disease	1.27e-05	5.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—coronary artery disease	1.27e-05	5.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK1—coronary artery disease	1.26e-05	5.24e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.26e-05	5.22e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—coronary artery disease	1.26e-05	5.21e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—coronary artery disease	1.26e-05	5.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—coronary artery disease	1.26e-05	5.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOA1—coronary artery disease	1.24e-05	5.15e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—coronary artery disease	1.23e-05	5.11e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—coronary artery disease	1.23e-05	5.11e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—coronary artery disease	1.23e-05	5.1e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK14—coronary artery disease	1.22e-05	5.07e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGF2—coronary artery disease	1.22e-05	5.05e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.21e-05	5.01e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—coronary artery disease	1.21e-05	5e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—coronary artery disease	1.2e-05	4.98e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—coronary artery disease	1.2e-05	4.98e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—F2—coronary artery disease	1.19e-05	4.92e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FN1—coronary artery disease	1.19e-05	4.92e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6ST—coronary artery disease	1.18e-05	4.9e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GSK3B—coronary artery disease	1.18e-05	4.89e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NFKBIA—coronary artery disease	1.17e-05	4.86e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—POMC—coronary artery disease	1.17e-05	4.85e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CREB1—coronary artery disease	1.17e-05	4.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGF2—coronary artery disease	1.17e-05	4.84e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JAK2—coronary artery disease	1.17e-05	4.84e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—coronary artery disease	1.15e-05	4.77e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—coronary artery disease	1.15e-05	4.75e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—coronary artery disease	1.14e-05	4.74e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6R—coronary artery disease	1.14e-05	4.73e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—coronary artery disease	1.14e-05	4.73e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—coronary artery disease	1.14e-05	4.71e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—coronary artery disease	1.13e-05	4.67e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK1—coronary artery disease	1.12e-05	4.65e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—JAK2—coronary artery disease	1.12e-05	4.64e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—coronary artery disease	1.1e-05	4.55e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GSK3B—coronary artery disease	1.09e-05	4.52e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—coronary artery disease	1.08e-05	4.48e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CREB1—coronary artery disease	1.08e-05	4.48e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—coronary artery disease	1.07e-05	4.44e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—coronary artery disease	1.07e-05	4.43e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—coronary artery disease	1.07e-05	4.42e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL2—coronary artery disease	1.06e-05	4.38e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6R—coronary artery disease	1.05e-05	4.37e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—coronary artery disease	1.05e-05	4.34e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—coronary artery disease	1.04e-05	4.31e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF2—coronary artery disease	1.04e-05	4.29e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK1—coronary artery disease	1.03e-05	4.29e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—coronary artery disease	1.03e-05	4.27e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK1—coronary artery disease	1.03e-05	4.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—coronary artery disease	1.02e-05	4.23e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—coronary artery disease	1.02e-05	4.23e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—coronary artery disease	1.02e-05	4.23e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—coronary artery disease	1.01e-05	4.2e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—coronary artery disease	9.93e-06	4.11e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—JAK2—coronary artery disease	9.93e-06	4.11e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—coronary artery disease	9.89e-06	4.1e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—coronary artery disease	9.87e-06	4.09e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—coronary artery disease	9.87e-06	4.09e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—coronary artery disease	9.78e-06	4.05e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—coronary artery disease	9.73e-06	4.03e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—coronary artery disease	9.72e-06	4.03e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—coronary artery disease	9.64e-06	3.99e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF2—coronary artery disease	9.56e-06	3.96e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—coronary artery disease	9.52e-06	3.94e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—coronary artery disease	9.43e-06	3.91e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—coronary artery disease	9.35e-06	3.87e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—coronary artery disease	9.24e-06	3.83e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JAK2—coronary artery disease	9.16e-06	3.8e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—coronary artery disease	9.06e-06	3.75e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—coronary artery disease	8.98e-06	3.72e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—coronary artery disease	8.96e-06	3.71e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—coronary artery disease	8.92e-06	3.7e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—coronary artery disease	8.75e-06	3.63e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—coronary artery disease	8.67e-06	3.59e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—coronary artery disease	8.66e-06	3.59e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—coronary artery disease	8.62e-06	3.57e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—coronary artery disease	8.44e-06	3.5e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—coronary artery disease	8.36e-06	3.46e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—coronary artery disease	8.3e-06	3.44e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—coronary artery disease	8.2e-06	3.4e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—coronary artery disease	8.08e-06	3.35e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—coronary artery disease	8e-06	3.32e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—coronary artery disease	7.95e-06	3.29e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—coronary artery disease	7.95e-06	3.29e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—coronary artery disease	7.94e-06	3.29e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—coronary artery disease	7.9e-06	3.27e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK1—coronary artery disease	7.79e-06	3.23e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—coronary artery disease	7.79e-06	3.23e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—coronary artery disease	7.62e-06	3.16e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—coronary artery disease	7.56e-06	3.13e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK1—coronary artery disease	7.47e-06	3.09e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—coronary artery disease	7.36e-06	3.05e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—coronary artery disease	7.34e-06	3.04e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—coronary artery disease	7.29e-06	3.02e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—coronary artery disease	6.79e-06	2.81e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—coronary artery disease	6.76e-06	2.8e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—coronary artery disease	6.75e-06	2.8e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK1—coronary artery disease	6.62e-06	2.74e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—coronary artery disease	6.48e-06	2.69e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—coronary artery disease	6.23e-06	2.58e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK1—coronary artery disease	6.11e-06	2.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—coronary artery disease	5.99e-06	2.48e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—coronary artery disease	5.75e-06	2.38e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—coronary artery disease	5.74e-06	2.38e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—coronary artery disease	5.52e-06	2.29e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—coronary artery disease	5.3e-06	2.2e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—coronary artery disease	5.29e-06	2.19e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—coronary artery disease	5.09e-06	2.11e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—coronary artery disease	4.7e-06	1.95e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—coronary artery disease	4.7e-06	1.95e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—coronary artery disease	4.33e-06	1.8e-05	CbGpPWpGaD
